Physician

Louis Cai

According to 2025 Medicare claims, Louis Cai (NPI: 1194220632) practices ophthalmology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is RETINAL DIAGNOSTIC CENTER A MEDICAL CORPORATION (NPI: 1518030568; TIN: 942711267) and primary practice location at 95076-2491.

Cai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 382 traditional Medicare patients, billed 5,353 HCPCS/CPT codes, and received $246,865 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 238 prescription claims across 107 beneficiaries totaling $12,013 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 18 records totaling $796. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$123K$247K2022 Medicare payment: $1,524 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,196 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $246,865 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222727$1,524
20238385$5,196
20243825,353$246,865

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$55K2018 Drug cost: $1,114 (USD; Tot_Drug_Cst)2019 Drug cost: $7,165 (USD; Tot_Drug_Cst)2020 Drug cost: $32,777 (USD; Tot_Drug_Cst)2021 Drug cost: $54,580 (USD; Tot_Drug_Cst)2022 Drug cost: $45,144 (USD; Tot_Drug_Cst)2023 Drug cost: $23,615 (USD; Tot_Drug_Cst)2024 Drug cost: $12,013 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181225$1,114
201957110$7,165
2020205554$32,777
2021233678$54,580
2022163505$45,144
2023100233$23,615
2024107238$12,013

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more106106$151
92014Established patient complete exam of visual system177190$116
67028Injection of drug into eye106136$111
92134Imaging of retina338415$38
J2777Injection, faricimab-svoa, 0.1 mg514,080$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate471,197$1,509
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat322,445$438
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha31752$330
ValacyclovirValacyclovir Hcl11755$268
Ketorolac TromethamineKetorolac Tromethamine14482$237

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$796Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Louis Cai?

Tedicare shows public-source Medicare data for Louis Cai (NPI 1194220632), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Louis Cai have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Louis Cai?

Louis Cai is linked to RETINAL DIAGNOSTIC CENTER A MEDICAL CORPORATION (billing NPI 1518030568) in the available physician profile data.

Does Louis Cai have Open Payments data?

Louis Cai has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.